Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking

Journal of Clinical Oncology

Volumn 21, Issue 5, 2003, Pages 914-920

  Hurt, Richard D ^a   Krook, James E ^b   Croghan, Ivana T ^b   Loprinzi, Charles L ^b   Sloan, Jeff A ^b   Novotny, Paul J ^b   Kardinal, Carl G ^b   Knost, James A ^b   Tirona, Maria Tria ^b   Addo, Ferdinand ^b   Morton, Roscoe F ^b   Michalak, John C ^b   Schaefer, Paul L ^b   Porter, Patricia A ^b   Stella, Philip J ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; PLACEBO; DOPAMINE UPTAKE INHIBITOR; NICOTINE;

ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SMOKING CESSATION; SMOKING HABIT; TREATMENT DURATION; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG COMBINATION; FEMALE; FOLLOW UP; MALE; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; SMOKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BUPROPION; DELAYED-ACTION PREPARATIONS; DOPAMINE UPTAKE INHIBITORS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; RECURRENCE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 0037366116     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.08.160     Document Type: Article

References (25)

1. Hughes JR, Goldstein MG, Hurt RD, et al: Recent advances in the pharmacotherapy of smoking. J Am Med Assoc 281:72-76, 1999
2. Hurt RD, Dale LC, Fredrickson PA, et al: Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up-One-year outcome and percentage nicotine replacement. J Am Med Assoc 271:595-600, 1994
3. Fiore MC, Bailey WC, Cohen SJ, et al: Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, MD, US Department of Health and Human Services, Public Health Service, 2000
4. Fredrickson PA, Hurt RD, Lee GM, et al: Safety and tolerability of high dose transdermal nicotine therapy for heavy smokers. Psychopharmacology 122:215-222, 1995
5. Dale LC, Hurt RD, Offord KP, et al: High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. J Am Med Assoc 274:1353-1358, 1995
6. Hughes JR, Lesmes GR, Hatsukami DK, et al: Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1:169-174, 1999
7. Zevin S, Jacob P, Benowitz NL: Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther 64:87-95, 1998
8. Killen JD, Fortmann SP, Davis L, et al: Do heavy smokers benefit from higher dose nicotine patch therapy? Exp Clin Psychopharmacol 7:226-233, 1999
9. Jorenby DE, Smith SS, Fiore MC, et al: Varying nicotine patch dose and type of smoking cessation counseling. J Am Med Assoc 274:1347-1352, 1995
10. Hughes JR: Treatment of nicotine dependence. Is more better? J Am Med Assoc 274:1390-1391, 1995
11. Tønnesen P, Paoletti P, Gustavsson G, et al: Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Eur Respir J 13:238-246, 1999
12. Hurt RD, Sachs DPL, Glover ED, et al: A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195-1202, 1997
13. Jorenby DE, Leischow SJ, Nides M, et al: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685-691, 1999
14. Hays JT, Hurt RD, Rigotti NA, et al: Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Ann Intern Med 135:423-433, 2001
15. Heatherton TF, Kozlowski LT, Frecker RC, et al: The Fagerström test for nicotine dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119-1127, 1991
16. Ware JE, Sherbourne CD: The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36): Conceptual framework and item selection. Med Care 30:473-483, 1992
17. Swenson WM, Morse RM: The use of a Self-Administered Alcoholism Screening Test (SAAST) in a medical center. Mayo Clin Proc 50:204-208, 1975
18. Pocock SR, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103-115, 1975
19. Croghan GA, Sloan JA, Croghan IT, et al: Comparison of a 15 mg/16 hour nicotine patch alone versus nicotine nasal spray alone versus both for treating smokers: A randomized multicenter trial in a community practice setting. Nicotine Tob Res (in press)
20. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ, Lawrence Erlbaum, 1988
21. Moses L, Emerson J, Hosseini H: Analyzing data from ordered categories. N Engl J Med 311:442-448, 1984
22. McCullagh P, Nelder JA: Generalized Linear Models. Chapman and Hall Ltd, New York, 1983
23. Agresti A: Categorical Data Analysis. John Wiley and Sons, New York, 1990
24. Moses LE, Emerson JD, Hosseini H: Analyzing data from ordered categories. N Engl J Med 311:442-448, 1984
25. Tønnesen P, Norregaard J, Sawe U, et al: Recycling with nicotine patches in smoking cessation. Addiction 88:533-539, 1993